Adding Herbal Products to Direct-Acting Oral Anticoagulants Can Be Fatal

Affiliations

01 January 2019

-

doi: 10.12890/2019_001190


Abstract

Direct-acting oral anticoagulants (DOACs) are used to prevent and treat systemic and cerebral embolisms in patients with non-valvular atrial fibrillation (NV-AF). The use of DOACs with herbal products without consulting healthcare professionals increases the possibility of drug-herb interactions and their adverse effects. An 80-year-old man on dabigatran with a known history of NV-AF presented with a 1-day history of haematemesis and black stool which began 3 days after he had started taking a boiled mixture of ginger and cinnamon. The patient was hypotensive and treated as a case of gastrointestinal bleeding and haemorrhagic shock. Despite continuous aggressive resuscitation measures including administration of a reversal agent for dabigatran, we were unable to control bleeding and the patient died within 24 hours. The interaction of ginger and cinnamon with dabigatran led to fatal bleeding.

Learning points: Direct-acting oral anticoagulants (DOACs) are frequently prescribed for patients with non-valvular atrial fibrillation.Combining herbal products (ginger and cinnamon) with DOACs can be fatal.Physicians should alert patients and caregivers about dangerous combinations and interactions.

Keywords: Ginger; cinnamon; dabigatran.

Conflict of interest statement

Conflicts of Interests: The Authors declare that there are no competing interests.


Similar articles

Major Bleeding Risk in Patients With Non-valvular Atrial Fibrillation Concurrently Taking Direct Oral Anticoagulants and Antidepressants.

Chang KH, Chen CM, Wang CL, Tu HT, Huang YT, Wu HC, Chang CH, Chang SH.Front Aging Neurosci. 2022 Feb 4;14:791285. doi: 10.3389/fnagi.2022.791285. eCollection 2022.PMID: 35185526 Free PMC article.

Does type 2 diabetes affect the on-treatment levels of direct oral anticoagulants in patients with atrial fibrillation?

Samoš M, Bolek T, Stančiaková L, Škorňová I, Ivanková J, Kovář F, Galajda P, Kubisz P, Staško J, Mokáň M.Diabetes Res Clin Pract. 2018 Jan;135:172-177. doi: 10.1016/j.diabres.2017.11.024. Epub 2017 Nov 23.PMID: 29175298

Reversal strategies in patients treated with direct oral anticoagulants.

Gressenberger P.Vasa. 2019 Aug;48(5):389-392. doi: 10.1024/0301-1526/a000777. Epub 2019 Feb 5.PMID: 30719950

Efficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin in Prevention of Thromboembolic Events Among Elderly Patients with Atrial Fibrillation.

Kailas SD, Thambuluru SR.Cureus. 2016 Oct 18;8(10):e836. doi: 10.7759/cureus.836.PMID: 27900231 Free PMC article. Review.

Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation.

Salazar CA, del Aguila D, Cordova EG.Cochrane Database Syst Rev. 2014 Mar 27;2014(3):CD009893. doi: 10.1002/14651858.CD009893.pub2.PMID: 24677203 Free PMC article. Review.


Cited by

Dietary supplements and bleeding.

Hatfield J, Saad S, Housewright C.Proc (Bayl Univ Med Cent). 2022 Sep 15;35(6):802-807. doi: 10.1080/08998280.2022.2121575. eCollection 2022.PMID: 36304597 Free PMC article. Review.

Herb-Drug Interaction in Inflammatory Diseases: Review of Phytomedicine and Herbal Supplements.

Lippert A, Renner B.J Clin Med. 2022 Mar 12;11(6):1567. doi: 10.3390/jcm11061567.PMID: 35329893 Free PMC article. Review.

Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics.

Sánchez-Fuentes A, Rivera-Caravaca JM, López-Gálvez R, Marín F, Roldán V.Front Cardiovasc Med. 2022 Jan 17;8:787235. doi: 10.3389/fcvm.2021.787235. eCollection 2021.PMID: 35111826 Free PMC article. Review.

The Clinical Significance of Drug-Food Interactions of Direct Oral Anticoagulants.

Grześk G, Rogowicz D, Wołowiec Ł, Ratajczak A, Gilewski W, Chudzińska M, Sinkiewicz A, Banach J.Int J Mol Sci. 2021 Aug 8;22(16):8531. doi: 10.3390/ijms22168531.PMID: 34445237 Free PMC article. Review.

Centella asiatica Water Extract Shows Low Potential for Cytochrome P450-Mediated Drug Interactions.

Wright KM, Magana AA, Laethem RM, Moseley CL, Banks TT, Maier CS, Stevens JF, Quinn JF, Soumyanath A.Drug Metab Dispos. 2020 Oct;48(10):1053-1063. doi: 10.1124/dmd.120.090860. Epub 2020 Jun 24.PMID: 32581050 Free PMC article.


KMEL References


References

  1.  
    1. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, Jr, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019 Jan 21; pii: S0735-1097(19)30209-8 [Epub ahead of print] - PubMed
  2.  
    1. Shi S, Klotz U. Drug interactions with herbal medicines. Clin Pharmacokinet. 2012;51(2):77–104. - PubMed
  3.  
    1. Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of herbal medicine use by UK patients/consumers: a systematic review of surveys. Focus Altern Complement Ther. 2013;18(1):19–26.
  4.  
    1. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837–847. - PMC - PubMed
  5.  
    1. Di Minno A, Frigerio B, Spadarella G, Ravani A, Sansaro D, Amato M, et al. Old and new oral anticoagulants: food, herbal medicines and drug interactions. Blood Rev. 2017;31(4):193–203. - PubMed
  6.  
    1. Woehrlin F, Fry H, Abraham K, Preiss-Weigert A. Quantification of flavoring constituents in cinnamon: high variation of coumarin in cassia bark from the German retail market and in authentic samples from Indonesia. J Agric Food Chem. 2010;58(19):10568–10575. - PubMed
  7.  
    1. Verma SK, Singh J, Khamesra R, Bordia A. Effect of ginger on platelet aggregation in man. Indian J Med Res. 1993;98:240–242. - PubMed
  8.  
    1. Buhner SH. Herbal antibiotics: natural alternatives for treating drug-resistant bacteria. 2nd ed. North Adams, MA, USA: Storey Publishing; 2012.